Patient Journey and Treatment Protocol Our clinical practice has developed a well-laid-out approach that helps patients succeed with semaglutide treatment
regular monitoring by a healthcare provider is advised
0.25 mg, 0.50 mg, 1.0 mg, 1.7 mg, 2.4 mg for Wegovy)
However, if nausea, vomiting, or other effects remain severe after two months at a given dose, you may not tolerate semaglutide well
Months 2-3: Many people lose 5-10% of their starting weight
This view may reflect concerns that the medications will bypass traditional habit-building practices such as diet and exercise (the reason cited by 60% of respondents), or that they are a temporary fix (52%)